You are here: Industry Insights > biomarker

News List

FDA approves an oncology drug that targets a key genetic driver of cancer, rather than a specific type of tumor fda
November 28, 2018
The U.S. Food and Drug Administration today granted accelerated approval to Vitrakvi (larotrectinib), a treatment for adult and pediatric patients whose cancers have a specific genetic feature (biomarker).
Bristol-Myers racks up Opdivo combo data to sell its new biomarker, but will doctors buy it? fiercepharma
June 05, 2018
Bristol-Myers Squibb’s new strategy In lung cancer relies on showing its new biomarker can help predict who benefits most from immunotherapy combinations.
Certain iron supplements may influence the development of colon cancer europeanpharmaceuticalreview
April 17, 2018
Two common iron compounds increase the formation of a known biomarker for cancer…
University of Oxford gains access to biomarker profiling technology pharmafiles
May 10, 2017
The University of Oxford has announced that it will benefit from Nightingale Health’s biomarker analysis technology. The Finnish company will install its technology in the Nuffield Department of Population Health (NPDH), in the Wolfson Laboratory.

Previous page 1 2 Next page